Quantifying the persisting orphan-drug shortage public health crisis in the United States

Background: Orphan drugs (ODs) are pharmaceuticals manufactured for rare conditions that affect less than 200,000 people in the US. ODs are therefore produced in small quantities to meet sparse demand. Since 2010, OD shortages have become frequent, but no comprehensive, quantitative studies exist. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarosławski, Szymon, Azaiez, Chiraz, Korchagina, Daria, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560412/
https://www.ncbi.nlm.nih.gov/pubmed/28839523
http://dx.doi.org/10.1080/20016689.2017.1269473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560412/
https://www.ncbi.nlm.nih.gov/pubmed/28839523
http://dx.doi.org/10.1080/20016689.2017.1269473

Ejemplares similares